Mcnamara exploratory chemistry
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,869,424
Award facts
- Opportunity
-
- NIHNINDS1701 Solicitation number
- Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Award Notice · Posted Mar 19, 2018
- Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Award Notice · Posted Jun 30, 2017
- Contract value 100% obligated
- $2,869,424.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$444,938 | |
| Funding Only Action | -$0 | |
| Exercise an Option | $1,434,146 | |
| Exercise an Option | $1,268,750 | |
| Original award | $611,466 |
About this award
This is a delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The $2,869,424.14 contract is for the provision of medicinal chemistry support services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract is focused on exploratory chemistry work to support therapeutic development across various disease areas, including neurology, infectious diseases, and substance abuse. Curia has extensive experience supporting federal agencies like NIH through prime and subcontract awards in areas such as drug discovery, development, and manufacturing. No set-aside designation was specified for this contract award.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 1, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $2,869,424 on 75N95019F00088.
Which agency awarded contract 75N95019F00088?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00088, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award